Wilmington, DE -- (SBWIRE) -- 01/10/2014 -- Equity Profile Report expands its NYSE Active Stock Weekly Watch List adding Merck & Co. Inc. (NYSE:MRK) and CEMEX, S.A.B. de C.V. (NYSE:CX).
Merck & Co. Inc. (NYSE:MRK) a company that provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide closed down in its previous session (-0.54%) on 9,328,168 shares traded after Merck Received FDA Approval for ISENTRESS for Pediatric Oral Suspension. Merck & Co. Inc. (NYSE:MRK) is currently down (-2.14%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.
Click Here to find out what other Investors are saying about Merck & Co. Inc. (NYSE:MRK)
CEMEX, S.A.B. de C.V. (NYSE:CX) a company that through its subsidiaries, engages in the production and sale of cement, ready-mix concrete, aggregates, and other construction materials in Mexico, the United States, Northern Europe, the Mediterranean, South America, the Caribbean, and Asia closed up in its previous session (+3.67%) on 17,885,275 shares traded after TheStreet Ratings team rated CEMEX SAB DE CV as a Hold with a ratings score of C-. CEMEX, S.A.B. de C.V. (NYSE:CX) is currently up (+33.63%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.
Click Here to find out what other Investors are saying about CEMEX, S.A.B. de C.V. (NYSE:CX)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)